Apollo Hospitals Enterprise Limited (BOM:508869)
India flag India · Delayed Price · Currency is INR
7,538.25
+1.10 (0.01%)
At close: Feb 13, 2026

BOM:508869 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
242,152217,940190,592166,125146,626105,600
Revenue
242,152217,940190,592166,125146,626105,600
Revenue Growth (YoY)
14.52%14.35%14.73%13.30%38.85%-6.11%
Cost of Revenue
159,199144,440126,608109,44695,31774,204
Gross Profit
82,95373,50063,98456,67951,30931,396
Selling, General & Admin
7,1857,1858,1047,8294,6692,635
Other Operating Expenses
40,37435,98331,93728,20424,74917,358
Operating Expenses
56,18650,74346,91142,18735,42525,724
Operating Income
26,76722,75717,07314,49215,8845,672
Interest Expense
-4,093-4,225-4,101-3,137-3,304-4,058
Interest & Investment Income
930930429445351218
Earnings From Equity Investments
453330180-432738
Currency Exchange Gain (Loss)
---36-41
Other Non Operating Income (Expenses)
-50-135-153-532-310-250
EBT Excluding Unusual Items
24,00719,65713,42810,83912,7001,549
Gain (Loss) on Sale of Investments
77477437428525389
Gain (Loss) on Sale of Assets
-63-63-36-150-40-29
Other Unusual Items
-1692339312,941606
Pretax Income
24,54920,39113,80511,00515,8542,215
Income Tax Expense
5,8915,3404,4552,5624,770847
Earnings From Continuing Operations
18,65815,0519,3508,44311,0841,368
Minority Interest in Earnings
-639-592-364-252-528136
Net Income
18,01914,4598,9868,19110,5561,504
Net Income to Common
18,01914,4598,9868,19110,5561,504
Net Income Growth
37.54%60.91%9.71%-22.40%601.86%-66.94%
Shares Outstanding (Basic)
144144144144144140
Shares Outstanding (Diluted)
144144144144144140
Shares Change (YoY)
-0.01%---2.71%0.62%
EPS (Basic)
125.33100.5662.5056.9773.4210.74
EPS (Diluted)
125.33100.5662.5056.9773.4210.74
EPS Growth
37.55%60.91%9.71%-22.40%583.57%-67.15%
Free Cash Flow
-4,2377,8342,48410,3889,692
Free Cash Flow Per Share
-29.4754.4817.2872.2569.23
Dividend Per Share
20.00019.00016.00015.00011.7503.000
Dividend Growth
5.26%18.75%6.67%27.66%291.67%-50.00%
Gross Margin
34.26%33.73%33.57%34.12%34.99%29.73%
Operating Margin
11.05%10.44%8.96%8.72%10.83%5.37%
Profit Margin
7.44%6.63%4.71%4.93%7.20%1.42%
Free Cash Flow Margin
-1.94%4.11%1.49%7.08%9.18%
EBITDA
32,12927,98222,11519,10620,4559,754
EBITDA Margin
13.27%12.84%11.60%11.50%13.95%9.24%
D&A For EBITDA
5,3625,2255,0424,6144,5714,082
EBIT
26,76722,75717,07314,49215,8845,672
EBIT Margin
11.05%10.44%8.96%8.72%10.83%5.37%
Effective Tax Rate
24.00%26.19%32.27%23.28%30.09%38.24%
Revenue as Reported
244,240219,943191,655167,028147,408106,050
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.